
AstraZeneca gets regulator’s nod to market cancer drug in India
The Hindu
AstraZeneca Pharma receives approval to market cancer treatment drug in India, expanding options for HER2-positive solid tumours.
More Related News

AstraZeneca Pharma receives approval to market cancer treatment drug in India, expanding options for HER2-positive solid tumours.